The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Growth In Market Size Of The Coronary Artery Disease Market During 2026–2030?
The coronary artery disease market has experienced swift expansion in its scale over recent years. It is anticipated to increase from $31.88 billion in 2025 to $35.27 billion in 2026, with a compound annual growth rate (CAGR) of 10.6%. The historical surge can be linked to the significant occurrence of cardiovascular disease, the adoption of sedentary lifestyles, tobacco consumption, insufficient knowledge about preventive care, and treatment approaches primarily based in hospitals.
The coronary artery disease market size is poised for substantial expansion in the coming years. Its valuation is projected to reach $53.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.2%. This anticipated growth during the forecast period is propelled by factors such as an aging global population, increasing obesity rates, advancements in diagnostic technologies, the proliferation of preventive cardiology initiatives, and enhanced healthcare accessibility. Key developments anticipated within this period involve a heightened emphasis on early disease detection, an uptick in the utilization of combination drug therapies, the expansion of lifestyle modification programs, a greater adoption of minimally invasive treatments, and the integration of cardiac rehabilitation services.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12052&type=smp
What Key Growth Drivers Are Influencing The Coronary Artery Disease Market?
The increasing incidence of coronary artery disease is projected to drive the expansion of the coronary artery disease market in the upcoming years. Coronary artery disease (CAD) is a health condition defined by the constriction or obstruction of the coronary arteries, which are responsible for delivering blood to the heart muscle. The number of coronary artery disease cases is growing, attributed to evolving dietary habits, elevated stress levels, insufficient physical activity, obesity, aging, and other factors. Treatment for coronary artery disease involves medications like clopidogrel, ticagrelor, warfarin, and heparin, alongside procedures such as coronary artery bypass grafting, angioplasty, and stenting. For example, data published in October 2025 by the Australian Institute of Health and Welfare, an Australian government body, indicated that in 2023, approximately 2,700 acute coronary events affected First Nations individuals aged 25 and above. When age-adjusted, this rate was 2.8 times higher compared to non-Indigenous populations. Consequently, the expanding prevalence of coronary artery disease is anticipated to stimulate the coronary artery disease market throughout the forecast period.
Which Segment Groups Define The Coronary Artery Disease Market Landscape?
The coronary artery disease market covered in this report is segmented –
1) By Treatment: Medication, Surgery, Additional Therapy, Other Treatments
2) By Diagnosis: Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterization, Heart CT Scan, Other Diagnosis
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Medication: Antiplatelet Agents, Beta-Blockers, Statins, ACE Inhibitors
2) By Surgery: Coronary Artery Bypass Grafting, Angioplasty And Stenting, Heart Valve Surgery
3) By Additional Therapy: Cardiac Rehabilitation, Lifestyle Modification Programs, Alternative Therapies
4) By Other Treatments: Gene Therapy, Stem Cell Therapy, Innovative Devices
What Trends Are Shaping The Coronary Artery Disease Market Structure?
Companies operating in the coronary artery disease market are concentrating on developing innovative products, such as drug-coated balloon catheters, to enhance market revenues. Drug-coated balloon catheters are medical devices employed in interventional cardiology to treat narrowed or blocked blood vessels, specifically in the context of coronary artery disease or peripheral artery disease. For example, in March 2024, Boston Scientific Corporation, a medical device company based in the US, announced that its AGENT Drug-Coated Balloon (DCB) received US Food and Drug Administration (FDA) approval. This device is indicated for managing coronary in-stent restenosis (ISR) in patients suffering from coronary artery disease. In-stent restenosis is characterized by the obstruction or narrowing of a stented vessel due to plaque or scar tissue. The AGENT DCB provides a specialized treatment solution for the challenging condition of in-stent restenosis (ISR), addressing a significant unmet medical need. It is specifically designed to treat ISR as well as previously untreated small vessel coronary disease. Available across Europe, various parts of Asia Pacific, and Latin America, the AGENT DCB offers a targeted approach for these complex cardiovascular conditions.
Which Companies Are Influencing The Coronary Artery Disease Market?
Major companies operating in the coronary artery disease market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Wockhardt Ltd., Kowa Pharmaceuticals America Inc., Barr Pharmaceuticals Inc., AdvanceCor GmbH, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V.
Access The Complete Coronary Artery Disease Market Report:
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report
Which Region Stands As The Largest Contributor To The Coronary Artery Disease Market?
North America was the largest region in the coronary artery disease market in 2025. The regions covered in the coronary artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Coronary Artery Disease Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12052&type=smp
Browse Through More Reports Similar to the Global Coronary Artery Disease Market 2026, By The Business Research Company
Coronary Artery Disease Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report
Aortic Stent Grafts Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/aortic-stent-grafts-global-market-report
Heart Transplant Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/heart-transplant-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model